Rabeprazole Sodium Market
Global Rabeprazole Sodium Market Size, Share and Trends Analysis Report, By Type (Rabeprazole Sodium Monohydrate and Rabeprazole Sodium Crystalline), By Application (Gastroesophageal Reflux Disease Treatment, Duodenal Ulcer Treatment, and Others), Forecast (2022-2028)
The global rabeprazole sodium market is expected to rise at a considerable CAGR during the forecast (2022-2028). The Rabeprazole sodium helps in reducing heartburn symptoms and other diseases caused by high stomach acids, such as ulcers or reflux, by reducing the quantity of acid produced in the stomach. It's used to treat gastroesophageal reflux disease (GERD), erosive esophagitis, and other disorders caused by too much stomach acid. The major factor driving the growth of the market include the increasing knowledge of the benefits of rabeprazole sodium and an increase in demand for proton pump inhibitors. Besides, the gastroesophageal reflux disease (GERD) and ulcers cases globally is further surging the growth of the rabeprazole sodium market. As per the Korean Society of Neurogastroenterology and Motility, the prevalence of GERD is 18.1–27.8% in North America, 8.8–25.9% in Europe, 2.5–7.8% in East Asia, 8.7–33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America in 2020. This is estimated to increase during the forecast along with the significant demand for rabeprazole sodium.
Segmental Outlook
The global rabeprazole sodium market is segmented based on type and application. Based on type, the market is sub-segmented into rabeprazole sodium monohydrate and rabeprazole sodium crystalline. . Based on application, the market is sub-segmented into gastroesophageal reflux disease treatment, duodenal ulcer treatment, and others. Among these, the gastroesophageal reflux diseases treatment segment is projected to grow at fastest CAGR during the forecast period. The huge base affected with gastroesophageal reflux diseases creates huge demand for rabeprazole sodium, which in turn drives the segment growth.
Global Rabeprazole Sodium Market Share by Type, 2021(%)
Rabeprazole Sodium Monohydrate Segment is Holding a Prominent Share in the Global Rabeprazole Sodium Market.
Among type segment, the rabeprazole sodium monohydrate has witnessed an increase in market share in 2021. During the projection period, the rabeprazole sodium sub-segment is predicted to hold the considerable market share owing to the increasing demand from pharmaceutical and healthcare industries. The market for rabeprazole sodium is now being driven by the need to reduce the risk of contamination. The rabeprazole sodium demand in pharmaceuticals and healthcare industry is predicted to expand which will positively affect the market growth.
Regional Outlooks
The global rabeprazole sodium market is further segmented based on geography Including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East and Africa, and Latin America). Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the presence of a huge population base, rapid R&D activities by pharma companies, and high healthcare investment by the population.
Global Rabeprazole Sodium Market Growth, by Region 2022-2028
The North America is Expected to Witness the Highest Growth Rate in the Global Rabeprazole Sodium Market.
The global rabeprazole sodium market has been led by the US in North America region, and this trend is expected to continue over the forecast period. The huge population base affected with gastroesophageal reflux disease (GERD), duodenal ulcers, and bacterial infections in the stomach in the country is the key factor enhancing the market growth. For instance, A systematic review by El-Serag et al. estimated the prevalence of GERD in the US is between 18.1% to 27.8%. Moreover, as per Cedars-Sinai Nationwide Study conducted by 71,000 people aged 18 or over across the U.S. in 2019, around 44.1% reported experiencing GERD symptoms in the past and more than a third of the GERD sufferers said they were therapy. In addition, of those taking daily proton pump inhibitors, 54.1% reported persistent GERD symptoms. The prevalence is projected to open new doors for the growth opportunities in the market during the forecast.
Market Players Outlook
The major companies serving the global rabeprazole sodium market include ASN Co., Intas Pharmaceutical Ltd., Pfizer Inc., Novartis International AG (Sandoz Inc.), Teva Pharmaceutical Industries Ltd., and others. To enhance their market share, industry participants are employing a number of critical techniques. For instance, SOFIE Biosciences, Inc. ("SOFIE"), a well-established radiopharmaceutical supplier and global radiopharmaceutical contract manufacturing company, and Jubilant Radiopharma, a business subsidiary of Jubilant Pharma Limited, announced a strategic agreement on November 4, 2020. According to the terms of the agreement, Jubilant Pharma will be a strategic partner to SOFIE, with a 25% equity stake in one of its wholly-owned subsidiaries, allowing SOFIE to expand production capacity, advance its theranostic pipeline, and support novel PET diagnostic manufacturing and distribution in the US.
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the Global Rabeprazole Sodium Market. Based on the availability of data, information related to new product launches, and relevant news is additionally available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Rabeprazole Sodium Market
• Recovery Scenario of Global Rabeprazole Sodium Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. ASN Corp.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Intas Pharmaceutical Ltd.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Pfizer Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. Swot Analysis
3.3.4. Recent Developments
3.4. Sandoz Inc (Novartis International AG )
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Teva Pharmaceutical Industries Ltd.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Rabeprazole Sodium Market by Type
4.1.1. Rabeprazole Sodium Monohydrate
4.1.2. Rabeprazole Sodium Crystalline
4.2. Global Rabeprazole Sodium Market by Application
4.2.1. Gastroesophageal Reflux Disease Treatment
4.2.2. Duodenal Ulcer Treatment
4.2.3. Others
5. Regional Analysis
5.1. North America
5.1.1 United States
5.1.2 Canada
5.2. Europe
5.2.1.UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Aytu Therapeutics, Inc.
6.2. Angita Pharma Inc.
6.3. Avadel Pharmaceuticals Plc
6.4. Cadila Pharmaceuticals Ltd.
6.5. CDx Diagnostics
6.6. Enal Drugs Pvt. Ltd.
6.7. Implantica AG
6.8. JSN Chemicals
6.9. Jubilant Pharma Ltd.
6.10. Livzon Pharmaceutical Group
6.11. Shandong Luoxin Pharmaceutical Group Stock co., ltd.
6.12. Syn-Tech Chem & Pharm Co. Ltd.
6.13. Smaart Pharmaceuticals
6.14. Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
6.15. Sterile India Pvt. Ltd.
1. GLOBAL RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL RABEPRAZOLE SODIUM MONOHYDRATE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL RABEPRAZOLE SODIUM CRYSTALLINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
5. GLOBAL RABEPRAZOLE SODIUM IN GASTROESOPHAGEAL REFLUX DISEASE TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
6. GLOBAL RABEPRAZOLE SODIUM IN DUODENAL ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
7. GLOBAL RABEPRAZOLE SODIUM IN OTHER TREATMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
8. GLOBAL RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028($ MILLION)
9. NORTH AMERICAN RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
10. NORTH AMERICAN RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
11. NORTH AMERICAN RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
12. EUROPEAN RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. EUROPEAN RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028($ MILLION)
14. EUROPEAN RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
15. ASIA-PACIFIC RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
18. REST OF THE WORLD L RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. REST OF THE WORLD RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. REST OF THE WORLD RABEPRAZOLE SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL RABEPRAZOLE SODIUM MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL RABEPRAZOLE SODIUM MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL RABEPRAZOLE SODIUM MARKET, 2021-2028 (%)
4. GLOBAL RABEPRAZOLE SODIUM MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL RABEPRAZOLE SODIUM MONOHYDRATE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL RABEPRAZOLE SODIUM CRYSTALLINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL RABEPRAZOLE SODIUM MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
8. GLOBAL RABEPRAZOLE SODIUM IN GASTROESOPHAGEAL REFLUX DISEASE TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL RABEPRAZOLE SODIUM IN DUODENAL ULCER TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL RABEPRAZOLE SODIUM IN OTHER TREATMENTS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL RABEPRAZOLE SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. US RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
13. CANADA RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
14. UK RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
15. FRANCE RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
16. GERMANY RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
17. ITALY RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
18. SPAIN RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
19. REST OF EUROPE RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
20. INDIA RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
21. CHINA RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
22. JAPAN RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
23. SOUTH KOREA RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF ASIA-PACIFIC RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF THE WORLD RABEPRAZOLE SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
